Clinical Trial Update: Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating tranexamic acid's effect on platelet aggregation in infants undergoing cardiopulmonary bypass has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defect

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Emory University | Conditions: Heart Defect, Congenital | Phase 4 | Status: WITHDRAWN